• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆中39-kDa I类组织相容性抗原的生化特性。一种源自跨膜结构域缺失的可分泌膜蛋白。

Biochemical characterization of 39-kDa class I histocompatibility antigen in plasma. A secretable membrane protein derived from transmembrane domain deletion.

作者信息

Haga J A, She J X, Kao K J

机构信息

Department of Pathology, University of Florida, Gainesville, Florida 32610.

出版信息

J Biol Chem. 1991 Feb 25;266(6):3695-701.

PMID:1995624
Abstract

Three human class I major histocompatibility antigens (HLA) with molecular masses of 44, 39, and 36 kDa were identified in plasma by immunoprecipitation and immunoblotting. Further biochemical characterization showed that these antigens in plasma could be fractionated by Sephacryl S-300 column chromatography into two different pools. The 44-kDa intact HLA heavy chains are detected only in pool I and have an apparent molecular weight of 200,000 as determined by calibrated gel filtration column chromatography. The 39- and 36-kDa HLA heavy chains are present only in pool II and have an apparent molecular weight of 50,000. HLA in pool I can be extracted by Triton X-114 detergent, but 39- and 36-kDa plasma HLA in pool II are water soluble and not extractable by Triton X-114. Amino acid sequences of NH2 termini for 44- and 39-kDa plasma HLA are identical to that of cellular HLA. In contrast, the NH2-terminal amino acid sequence for 36-kDa plasma HLA has not been reported previously for any other proteins. Since the loss of both transmembrane domain and cytoplasmic tail at the carboxyl terminus of HLA will generate a 36-kDa protein, the findings suggest that the 39-kDa HLA might be the product of alternatively spliced mRNA with deletion of the exon coding for transmembrane domain. By using polymerase chain reaction and DNA sequencing, the presence of alternatively spliced mRNA with deletion of the transmembrane domain exon was identified in mononuclear leukocytes of peripheral blood. This alternatively spliced HLA mRNA was not detectable in mononuclear leukocytes of an individual who had no 39-kDa plasma HLA. This finding indicates that the alternatively spliced mRNA in mononuclear leukocytes is responsible for the synthesis of a secretable class I HLA.

摘要

通过免疫沉淀和免疫印迹法在血浆中鉴定出三种分子量分别为44、39和36 kDa的人类I类主要组织相容性抗原(HLA)。进一步的生化特性分析表明,血浆中的这些抗原可通过Sephacryl S - 300柱色谱法分为两个不同的组分。仅在组分I中检测到44 kDa完整的HLA重链,经校准的凝胶过滤柱色谱法测定其表观分子量为200,000。39 kDa和36 kDa的HLA重链仅存在于组分II中,表观分子量为50,000。组分I中的HLA可用Triton X - 114去污剂提取,但组分II中39 kDa和36 kDa的血浆HLA是水溶性的,不能被Triton X - 114提取。44 kDa和39 kDa血浆HLA的NH2末端氨基酸序列与细胞HLA的相同。相比之下,36 kDa血浆HLA的NH2末端氨基酸序列此前尚未在任何其他蛋白质中报道过。由于HLA羧基末端跨膜结构域和细胞质尾巴的缺失会产生一种36 kDa的蛋白质,这些发现表明39 kDa的HLA可能是外显子编码跨膜结构域缺失的可变剪接mRNA的产物。通过聚合酶链反应和DNA测序,在外周血单个核白细胞中鉴定出了跨膜结构域外显子缺失的可变剪接mRNA。在没有39 kDa血浆HLA的个体的单个核白细胞中未检测到这种可变剪接的HLA mRNA。这一发现表明,单个核白细胞中的可变剪接mRNA负责可分泌的I类HLA的合成。

相似文献

1
Biochemical characterization of 39-kDa class I histocompatibility antigen in plasma. A secretable membrane protein derived from transmembrane domain deletion.血浆中39-kDa I类组织相容性抗原的生化特性。一种源自跨膜结构域缺失的可分泌膜蛋白。
J Biol Chem. 1991 Feb 25;266(6):3695-701.
2
Alternative splicing of HLA class I transcripts induced by IFN-gamma and TNF in fibroblasts: release of soluble HLA class I heavy chain and an associate protein.干扰素-γ和肿瘤坏死因子诱导成纤维细胞中HLA I类转录本的可变剪接:可溶性HLA I类重链和一种相关蛋白的释放
Cell Immunol. 1995 Apr 15;162(1):159-68. doi: 10.1006/cimm.1995.1064.
3
Evidence for the presence of the alternatively spliced HLA-G mRNA forms in human mononuclear cells from peripheral blood and umbilical cord blood.在外周血和脐带血的人单核细胞中存在可变剪接的HLA - G mRNA形式的证据。
Hum Immunol. 1995 Jul;43(3):237-41. doi: 10.1016/0198-8859(95)00008-r.
4
Soluble HLA-G molecule. An alternatively spliced HLA-G mRNA form candidate to encode it in peripheral blood mononuclear cells and human trophoblasts.可溶性HLA-G分子。一种在外周血单核细胞和人滋养层细胞中编码它的选择性剪接的HLA-G mRNA形式候选物。
Hum Immunol. 1995 Jul;43(3):231-6. doi: 10.1016/0198-8859(95)00009-s.
5
Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens.HLA-G转录本的可变剪接产生的蛋白质,其一级结构既类似于I类抗原,也类似于II类抗原。
Proc Natl Acad Sci U S A. 1992 May 1;89(9):3947-51. doi: 10.1073/pnas.89.9.3947.
6
A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4.可溶性 HLA - G 抗原由含有第 4 内含子的信使核糖核酸编码。
J Immunol. 1994 Dec 15;153(12):5516-24.
7
[Presence of alternatively spliced messenger RNA for HLA-A, -B and -C in platelets].
Beitr Infusionsther Transfusionsmed. 1994;32:288-92.
8
Targeted amplification of alternatively spliced transcripts of major histocompatibility complex class I heavy chain.主要组织相容性复合体I类重链可变剪接转录本的靶向扩增
J Immunol Methods. 1994 Dec 2;176(2):265-70. doi: 10.1016/0022-1759(94)90320-4.
9
Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway.通过可变RNA剪接途径分泌HLA - A和 - B抗原。
J Exp Med. 1986 May 1;163(5):1173-90. doi: 10.1084/jem.163.5.1173.
10
Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.主要组织相容性复合体II类基因表达的分子特征及抗原特异性T细胞反应的证实表明II类缺陷患者存在一种新的表型。
J Exp Med. 1995 Apr 1;181(4):1411-23. doi: 10.1084/jem.181.4.1411.

引用本文的文献

1
Framework of Intrinsic Immune Landscape of Dormant Prostate Cancer.潜伏性前列腺癌固有免疫景观的框架。
Cells. 2022 May 5;11(9):1550. doi: 10.3390/cells11091550.
2
Open MHC Class I Conformers: A Look through the Looking Glass.开放 MHC I 类构象:透过镜子看。
Int J Mol Sci. 2021 Sep 8;22(18):9738. doi: 10.3390/ijms22189738.
3
Soluble major histocompatibility complex molecules in immune regulation: highlighting class II antigens.可溶性主要组织相容性复合体分子在免疫调节中的作用:重点介绍 II 类抗原。
Immunology. 2018 Mar;153(3):315-324. doi: 10.1111/imm.12868. Epub 2017 Dec 11.
4
A potential role for shed soluble major histocompatibility class I molecules as modulators of neurite outgrowth.脱落的可溶性主要组织相容性复合体 I 分子作为神经突生长调节剂的潜在作用。
PLoS One. 2011 Mar 31;6(3):e18439. doi: 10.1371/journal.pone.0018439.
5
HLA-G and its role in implantation (review).人类白细胞抗原G及其在着床中的作用(综述)
J Assist Reprod Genet. 2007 Jul;24(7):288-95. doi: 10.1007/s10815-007-9148-3. Epub 2007 Jul 14.
6
Soluble HLA: patterns of expression in normal subjects, autoimmune diseases, and transplant recipients.可溶性人类白细胞抗原:正常受试者、自身免疫性疾病患者及移植受者中的表达模式
Rheumatol Int. 2005 Sep;25(7):491-500. doi: 10.1007/s00296-005-0585-y. Epub 2005 Jun 29.
7
Soluble HLA measurement in saliva and cerebrospinal fluid in Caucasian patients with multiple sclerosis: a preliminary study.白种人多发性硬化症患者唾液和脑脊液中可溶性 HLA 的检测:一项初步研究。
J Neuroinflammation. 2005 Jun 2;2:13. doi: 10.1186/1742-2094-2-13.
8
Soluble HLA-I (s-HLA-I) synthesis in systemic lupus erythematosus.系统性红斑狼疮中可溶性人类白细胞抗原I类分子(s-HLA-I)的合成
Rheumatol Int. 2003 Nov;23(6):294-300. doi: 10.1007/s00296-003-0306-3. Epub 2003 Jul 23.
9
New nucleotide sequence data on the EMBL File Server.欧洲分子生物学实验室文件服务器上的新核苷酸序列数据。
Nucleic Acids Res. 1991 Jul 25;19(14):4025-42. doi: 10.1093/nar/19.14.4025.